Meeting of the Parliament (Hybrid) 03 November 2020
I am grateful for that important question. I am not clinically qualified, in any respect, to say whether it is safe, but I am very happy to ask HPS to review, and to continue to review, the guidance, in the light of emerging evidence. That is a constant exercise, but it is really important that we do it.
On the question of testing, I will have a detailed discussion this week in order to plan some of those additional areas of testing of individuals who are asymptomatic, as I mentioned in my statement—such as designated visitors, visiting health and care professionals, and care-at-home staff—into the scaling up of our testing capacity. I will be happy to return with a further statement on testing as a whole—and, of course, to discuss it with my colleagues in the Opposition parties—so that members can debate that.